» Articles » PMID: 33251083

Identification of Potential MRNA Panels for Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) Diagnosis and Treatment Using Microarray Dataset and Bioinformatics Methods

Overview
Journal 3 Biotech
Publisher Springer
Specialty Biotechnology
Date 2020 Nov 30
PMID 33251083
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of the present investigation is to identify the differentially expressed genes (DEGs) between SARS-CoV-2 infected and normal control samples to investigate the molecular mechanisms of infection with SARS-CoV-2. The microarray data of the dataset E-MTAB-8871 were retrieved from the ArrayExpress database. Pathway and Gene Ontology (GO) enrichment study, protein-protein interaction (PPI) network, modules, target gene-miRNA regulatory network, and target gene-TF regulatory network have been performed. Subsequently, the key genes were validated using an analysis of the receiver operating characteristic (ROC) curve. In SARS-CoV-2 infection, a total of 324 DEGs (76 up- and 248 down-regulated genes) were identified and enriched in a number of associated SARS-CoV-2 infection pathways and GO terms. Hub and target genes such as TP53, HRAS, MAPK11, RELA, IKZF3, IFNAR2, SKI, TNFRSF13C, JAK1, TRAF6, KLRF2, CD1A were identified from PPI network, target gene-miRNA regulatory network, and target gene-TF regulatory network. Study of the ROC showed that ten genes (CCL5, IFNAR2, JAK2, MX1, STAT1, BID, CD55, CD80, HAL-B, and HLA-DMA) were substantially involved in SARS-CoV-2 patients. The present investigation identified key genes and pathways that deepen our understanding of the molecular mechanisms of SARS-CoV-2 infection, and could be used for SARS-CoV-2 infection as diagnostic and therapeutic biomarkers.

Citing Articles

A Histological Analysis and Detection of Complement Regulatory Protein CD55 in SARS-CoV-2 Infected Lungs.

Silawal S, Gogele C, Pelikan P, Werner C, Levidou G, Mahato R Life (Basel). 2024; 14(9).

PMID: 39337843 PMC: 11432792. DOI: 10.3390/life14091058.


Identification of critical genes associated with oxidative stress pathways in benzene-induced hematotoxicity.

He J, Peng C, Yang X, Li P, Bai J, Jia Q Heliyon. 2024; 10(15):e35427.

PMID: 39170214 PMC: 11336642. DOI: 10.1016/j.heliyon.2024.e35427.


In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing.

Alamin M, Rahaman M, Ferdousi F, Sarker A, Ali M, Hossen M PLoS One. 2024; 19(7):e0304425.

PMID: 39024368 PMC: 11257407. DOI: 10.1371/journal.pone.0304425.


Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches.

Ahmed F, Das A, Sumi M, Islam M, Rahman M, Rashid M Sci Rep. 2023; 13(1):19072.

PMID: 37925496 PMC: 10625598. DOI: 10.1038/s41598-023-46455-8.


Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections.

Salihefendic L, Ceko I, Besic L, Mulahuseinovic N, Durgut S, Pecar D Front Genet. 2023; 14:1240245.

PMID: 37795240 PMC: 10545899. DOI: 10.3389/fgene.2023.1240245.


References
1.
Ayukawa H, Matsubara T, Kaneko M, Hasegawa M, Ichiyama T, Furukawa S . Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection. Clin Exp Immunol. 2004; 137(1):151-5. PMC: 1809088. DOI: 10.1111/j.1365-2249.2004.02502.x. View

2.
Chen C, Zhu X, Xu W, Yang F, Zhang G, Wu L . IFNA2 p.Ala120Thr impairs the inhibitory activity of Interferon-α2 against the hepatitis B virus through altering its binding to the receptor. Antiviral Res. 2017; 147:11-18. DOI: 10.1016/j.antiviral.2017.09.015. View

3.
Wang J, Liu Y, Xie L, Li S, Qin X . Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: A case-control study. Clin Res Hepatol Gastroenterol. 2015; 40(3):288-296. DOI: 10.1016/j.clinre.2015.10.004. View

4.
Wasityastuti W, Yano Y, Ratnasari N, Triyono T, Triwikatmani C, Indrarti F . Protective effects of HLA-DPA1/DPB1 variants against Hepatitis B virus infection in an Indonesian population. Infect Genet Evol. 2016; 41:177-184. DOI: 10.1016/j.meegid.2016.03.034. View

5.
Salimi V, Ramezani A, Mirzaei H, Tahamtan A, Faghihloo E, Rezaei F . Evaluation of the expression level of 12/15 lipoxygenase and the related inflammatory factors (CCL5, CCL3) in respiratory syncytial virus infection in mice model. Microb Pathog. 2017; 109:209-213. DOI: 10.1016/j.micpath.2017.05.045. View